Quantum Biopharma (QNTM) Debt Ratio (2024 - 2026)

Quantum Biopharma (QNTM) has 3 years of Debt Ratio data on file, last reported at 0.03 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio rose 208.31% year-over-year to 0.03; the trailing twelve-month figure through Mar 2026 stood at 0.03 (up 208.31% YoY), and the FY2025 full-year result was 0.04, up 376.45% from the prior year.
• Debt Ratio declined to 0.03 in Q1 2026, from 0.04 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.04 in Q4 2025 to a low of 0.01 in Q4 2024.
• A 3-year average of 0.02 and a median of 0.02 in 2025 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio jumped 376.45% in 2025 and soared 208.31% in 2026, its largest moves.
• Tracing QNTM's Debt Ratio over 3 years: stood at 0.01 in 2024, then jumped by 376.45% to 0.04 in 2025, then declined by 23.16% to 0.03 in 2026.
• Business Quant data shows QNTM's Debt Ratio at 0.03 in Q1 2026, 0.04 in Q4 2025, and 0.03 in Q3 2025.